Status:
COMPLETED
Secondary Prophylaxis After Variceal Bleeding in Non-Responders
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
Gastrointestinal Hemorrhage
Portal Hypertension
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Controlled and randomized study comparing combined treatment (nadolol and endoscopic ligation) versus nadolol associated with isosorbide mononitrate or prazosin according to hemodynamic response, in t...
Detailed Description
The present is a prospective, randomized, open label study, in parallel groups, in which the patients with hemorrhage caused by esofagic varices will be randomized in two groups of treatment, after co...
Eligibility Criteria
Inclusion
- Any Patient with endoscopically assessed Variceal Bleeding (esofagic and gastric)
- Cirrhosis
- Patient agreement to be included in the study onsentiment signed
Exclusion
- Any associated comorbidity with life expectancy lesser than 6 months
- Patient refusement to be included in the study.
- Pregnancy
- Failure to control acute bleeding
- Previous prophylaxis treatment
Key Trial Info
Start Date :
November 1 2000
Trial Type :
INTERVENTIONAL
End Date :
June 1 2004
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00450164
Start Date
November 1 2000
End Date
June 1 2004
Last Update
March 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unidad de Sangrantes, HSCSP
Barcelona, Barcelona, Spain, 08025